» Articles » PMID: 6983404

Modulation of Polyclonal B Cell Differentiation by Human Leucocyte Alpha Interferon

Overview
Date 1982 Sep 1
PMID 6983404
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Although interferon (IFN) profoundly affects immune responses in animals, less is known about its immunoregulatory activity in man. Therefore, peripheral blood mononuclear cells (PBM) from 20 healthy volunteers were incubated with pokeweed mitogen (PWM) in the presence and absence of human leucocyte alpha interferon (IFN alpha). In 18/20 experiments, IFN alpha added at initiation of culture markedly suppressed PWM-induced generation of immunoglobulin secreting cells (IgSC). IFN alpha suppressed proliferative responses in all experiments but the degree of suppression was not correlated with concomitant suppression of IgSC responses. Suppressive activity was resistant to pH 2 treatment but sensitive to treatment with trypsin. Delayed addition of IFN alpha was associated with decreased suppression. Suppression was not due to non-specific cytotoxicity since we observed (1) comparable viabilities in cultures with or without IFN alpha and (2) negligible effect when IFN alpha was added for the final 24 hr of culture. The data confirm previously described effects of IFN on mitogen stimulated PBM and, more importantly, provide convincing evidence that IFN alpha regulates human B cell functions.

Citing Articles

Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies.

Khan W Cent Eur J Immunol. 2018; 43(1):58-68.

PMID: 29736147 PMC: 5927174. DOI: 10.5114/ceji.2018.74874.


Development of Sjögren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C.

Unoki H, Moriyama A, Tabaru A, Masumoto A, Otsuki M J Gastroenterol. 1996; 31(5):723-7.

PMID: 8887042 DOI: 10.1007/BF02347624.


Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

OGorman M, Oger J, Kastrukoff L Clin Exp Immunol. 1987; 67(1):66-75.

PMID: 2957131 PMC: 1542565.

References
1.
Boyum A . Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968; 97:77-89. View

2.
Lindahl P, Leary P, GRESSER I . Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci U S A. 1972; 69(3):721-5. PMC: 426543. DOI: 10.1073/pnas.69.3.721. View

3.
Leary P, GRESSER I . Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells. Nat New Biol. 1972; 237(73):120-1. DOI: 10.1038/newbio237120a0. View

4.
Braun W, Levy H . Interferon preparations as modifiers of immune responses. Proc Soc Exp Biol Med. 1972; 141(3):769-73. DOI: 10.3181/00379727-141-36868. View

5.
Chester T, Paucker K, Merigan T . Suppression of mouse antibody producing spleen cells by various interferon preparations. Nature. 1973; 246(5428):92-4. DOI: 10.1038/246092a0. View